Trial Profile
A study of everolimus in recipients of living related HLA-identical kidney transplants
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 22 Dec 2015
Price :
$35
*
At a glance
- Drugs Everolimus (Primary) ; Tacrolimus
- Indications Transplant rejection
- Focus Therapeutic Use
- 22 Dec 2015 New trial record